ArticleJournal of imaging informatics in medicine2026
ADGPT: A Prior-Guided and GPT-Empowered Framework for MRI-Based Alzheimer's Disease Diagnosis.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Existing artificial intelligence methods for Alzheimer's disease (AD) diagnosis predominantly emphasize classification performance while neglecting interpretability. Leveraging large language models (LLMs) for diagnostic reasoning to generate decisions alongside supporting rationales can improve interpretability, yet remains underexplored in neuroimaging-based AD diagnosis. We propose a prior-guided and GPT-empowered framework (ADGPT) for magnetic resonance imaging (MRI)-based AD diagnosis. We construct an AD prior knowledge collection (APKC) to provide priors for the LLM's diagnostic reasoning. The APKC integrates three information types: label text tokens, JSON-based default mode network (DMN) representations, and brain tissue volumes. For the label text tokens, we propose a label text-graph structure alignment paradigm, such that the aligned label text tokens enable the LLM to identify AD-related abnormal functional patterns from functional MRI. The JSON-based DMN representations encode DMN functional connectivity in a structured JSON format, enabling the LLM to analyze the functional characteristics of key brain regions. Brain tissue volumes are used to quantify brain atrophy revealed by structural MRI. Additionally, we design a customized prompt for AD diagnosis to provide task inputs and guide the reasoning process. Without fine-tuning the LLM, ADGPT enables joint analysis of functional and structural AD pathologies revealed by neuroimaging and provides case-level, traceable diagnostic rationales. Experiments on two databases demonstrate that ADGPT outperforms state-of-the-art methods, achieving accuracies of 0.914 and 0.825 for AD versus normal control (NC), 0.806 and 0.812 for AD versus mild cognitive impairment (MCI), and 0.886 and 0.784 for MCI versus NC. Moreover, interpretability analyses provide additional evidence supporting its interpretability.
Indexed as
Identifiers
42806197What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.